Manuel Osorio, PhD

CBER CATT/FDA
Senior Scientist for Emerging Technologies & Medical Countermeasures
Manuel Osorio is currently the lead for the Advanced Manufacturing Technologies portfolio in the Center for Biologics Evaluation and Research (CBER) at the U.S. Food and Drug Administration (FDA). Prior to this role, Dr. Osorio was a researcher/reviewer for 16 years in the Office of Vaccines Research and Review in CBER. He received a BS degree from UCLA in Biochemistry and PhD degree in cellular immunology from the University of California at Santa Cruz. He was a postdoctoral fellow at the National Institutes of Health for two years before joining the FDA.